Therapeutic effects of the PKR inhibitor C16 suppressing tumor proliferation and angiogenesis in hepatocellular carcinoma in vitro and in vivo
Takao Watanabe(Miyoshi Kasei (Japan)), Yoichi Hiasa(Ehime University Hospital), Masashi Hirooka(Ehime University), Masanori Abe(Ehime University), Yusuke Imai(Ehime University), Takeshi Imamura(Ehime University), Osamu Yoshida(Ehime University Hospital), Shin Yamamoto(Massachusetts General Hospital), Hiroko Ninomiya(Ehime University), Takashi Saitou(Ehime University Hospital), Ryosuke Kawakami(Ehime University), Sota Takanezawa(Ehime University)
Cited by 33
Related Papers
Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors
|Oncogene|1999|693
Evidence-based clinical practice guidelines for Liver Cirrhosis 2020
|Journal of Gastroenterology|2021|424
A Glycine-rich RNA-binding Protein Mediating Cold-inducible Suppression of Mammalian Cell Growth
|The Journal of Cell Biology|1997|388
Detection of urovirulence factors in<i>Escherichia coli</i>by multiplex polymerase chain reaction
|FEMS Immunology & Medical Microbiology|1995|317
Genetic Evidence Supporting the Fecal-Perineal-Urethral Hypothesis in Cystitis Caused by Escherichia Coli
|The Journal of Urology|1997|281